High-dose-rate brachytherapy in the management of high-grade intraepithelial neoplasia of the vagina. 1997

C MacLeod, and A Fowler, and C Dalrymple, and K Atkinson, and P Elliott, and J Carter
Department of Radiation Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

The majority of women with high-grade intraepithelial neoplasia (VAIN 3) are over 60 years of age and have a history of premalignant or malignant disease of the cervix. Although the natural history of VAIN is not well defined, high-grade lesions are premalignant. Ablative treatment with laser or 5-fluorouracil cream is commonly unsatisfactory. Several series have reported a low rate of recurrence and complications if VAIN 3 is treated with low-dose-rate brachytherapy. This retrospective review reports the outcome of 14 patients treated with high-dose-rate brachytherapy, with a dose of 34 to 45 Gy in 4.5- to 8.5-Gy fractions. Treatment was well tolerated with no severe early or late toxicity observed. At a median follow-up of 46 months 1 patient progressed to invasive carcinoma of the vagina; in another patient VAIN 3 persisted.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D001918 Brachytherapy A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues. Curietherapy,Implant Radiotherapy,Plaque Therapy, Radioisotope,Radioisotope Brachytherapy,Radiotherapy, Interstitial,Radiotherapy, Intracavity,Radiotherapy, Surface,Brachytherapy, Radioisotope,Interstitial Radiotherapy,Intracavity Radiotherapy,Radioisotope Plaque Therapy,Radiotherapy, Implant,Surface Radiotherapy,Therapy, Radioisotope Plaque
D002278 Carcinoma in Situ A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane. Carcinoma, Intraepithelial,Carcinoma, Preinvasive,Intraepithelial Neoplasms,Neoplasms, Intraepithelial,Intraepithelial Carcinoma,Intraepithelial Neoplasm,Neoplasm, Intraepithelial,Preinvasive Carcinoma
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C MacLeod, and A Fowler, and C Dalrymple, and K Atkinson, and P Elliott, and J Carter
January 2011, The oncologist,
C MacLeod, and A Fowler, and C Dalrymple, and K Atkinson, and P Elliott, and J Carter
April 2019, Journal of contemporary brachytherapy,
C MacLeod, and A Fowler, and C Dalrymple, and K Atkinson, and P Elliott, and J Carter
March 1998, International journal of radiation oncology, biology, physics,
C MacLeod, and A Fowler, and C Dalrymple, and K Atkinson, and P Elliott, and J Carter
January 2014, Cancer research and treatment,
C MacLeod, and A Fowler, and C Dalrymple, and K Atkinson, and P Elliott, and J Carter
March 2013, Clinical obstetrics and gynecology,
C MacLeod, and A Fowler, and C Dalrymple, and K Atkinson, and P Elliott, and J Carter
March 2004, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
C MacLeod, and A Fowler, and C Dalrymple, and K Atkinson, and P Elliott, and J Carter
January 2004, Reviews in urology,
C MacLeod, and A Fowler, and C Dalrymple, and K Atkinson, and P Elliott, and J Carter
May 2012, Korean journal of urology,
C MacLeod, and A Fowler, and C Dalrymple, and K Atkinson, and P Elliott, and J Carter
January 1998, Tumori,
C MacLeod, and A Fowler, and C Dalrymple, and K Atkinson, and P Elliott, and J Carter
December 2023, European journal of obstetrics, gynecology, and reproductive biology,
Copied contents to your clipboard!